Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Blood Advances|June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium AnalysisKitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Journal of Geriatric Oncology|April 4, 2019
Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study GroupKitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, et al.
Annals of Hematology|October 19, 2016
Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registryKitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, et al.
Hematological Oncology|November 9, 2019
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphomaKitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, et al.
Leukemia & Lymphoma|June 24, 2020
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study GroupKitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, et al.
Annals of Hematology|May 18, 2023
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG)Thanawat Rattanathammethee, Lalita Norasetthada, Udomsak Bunworasate, et al.
Blood Advances|July 3, 2020
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortalityKitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, et al.
Annals of Hematology|September 17, 2023
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study GroupRonakrit Thanhakun, Kitsada Wudhikarn, Udomsak Bunworasate, et al.
Hematology Reports|December 24, 2025
Mucosal-Associated Lymphoid Tissue Lymphoma in Southeast Asia: A 15-Year Retrospective Multicenter StudyKannadit Prayongratana, Tanapun Thamgrang, Chonlada Laoruangroj, et al.
Pageof 8